Form 8-K - Current report:
SEC Accession No. 0001641172-25-020227
Filing Date
2025-07-18
Accepted
2025-07-18 16:15:28
Documents
17
Period of Report
2025-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42887
2 EX-4.1 ex4-1.htm EX-4.1 126339
3 EX-4.2 ex4-2.htm EX-4.2 126375
4 EX-10.1 ex10-1.htm EX-10.1 65045
5 GRAPHIC ex4-1_001.jpg GRAPHIC 1174
6 GRAPHIC ex4-2_001.jpg GRAPHIC 1174
  Complete submission text file 0001641172-25-020227.txt   584540

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE abeo-20250718.xsd EX-101.SCH 3044
8 XBRL LABEL FILE abeo-20250718_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE abeo-20250718_pre.xml EX-101.PRE 22378
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3679
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 251134682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)